Top Markets
Coin of the day
Theraclion SA Theraclion SA

Theraclion SA

ALTHE
株式のランク #15409
Theraclion SA develops echotherapy solutions using high intensity focused... Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. The company was founded in 2004 and is based in Malakoff, France.
株価
$0.78404857
時価総額
$36.98M
変化(1日)
-1.49%
変化(1年)
139.26%
FR
取引 Theraclion SA (ALTHE)

カテゴリー

Theraclion SA(ALTHE)の収益
Dec 2025 時点の収益 TTM: $1.39M
Theraclion SA の最新の財務報告によると、現在の収益 (TTM) は $1.39M です。2023 年には $2.01M の収益があり、これは 2022 年の $1.33M と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Theraclion SA の収益履歴(2010 ~ 2026)
各年末の収益
収益 変化
2026 (TTM) $1.39M 61.11%
2024 $863.67K -57.13%
2023 $2.01M 52.00%
2022 $1.33M -21.31%
2021 $1.68M 85.86%
2020 $906.10K -70.99%
2019 $3.12M 40.16%
2018 $2.23M -34.24%
2017 $3.39M 63.08%
2016 $2.08M 19.81%
2015 $1.73M 74.90%
2014 $991.77K 842.78%
2013 $105.20K 2,658,182.40%
2012 $3.96 -100.00%
2011 $1.21M 326.21%
2010 $284.72K 0.00%
同業他社の収益
企業 収益 収益の差
$45.13B 3,243,459.15%
US
$25.27B 1,815,930.93%
US
$36.37B 2,613,687.24%
IE
$20.62B 1,481,398.91%
US
$6.30B 452,901.62%
US